Functional MRI technologies in the study of medication treatment effect on Alzheimer's disease
Authors:
Open Access
- 23 April 2018
- journal article
- review article
- Published by Wiley in Aging Medicine
- Vol. 1 (1) , 75-95
Abstract
Alzheimer's disease (AD) is the most common cause of late‐life dementia. Characterized by progressive neurodegeneration, the disease is expressed as gradual memory loss together with decline in cognitive abilities and other brain functions. Despite extensive research over the past decade, the cause and cure of AD both remain largely unknown. Several AD‐associated deficits have been targeted for interventions, including those based on amyloid‐beta, tau, and inflammation hypotheses. Only 2 types of medications—cholinesterase inhibitors and memantine—have been approved, to control the cognitive symptoms of AD such as the loss of memory, language, and executive function. Noninvasive in vivo functional magnetic resonance imaging (MRI) technologies, including the blood oxygen level‐dependent functional MRI, arterial spin labeling‐based perfusion MRI, and the proton magnetic resonance spectroscopy have been used to study the effect of ChEIs and memantine in the brain. Most of these studies have demonstrated increased functional activation and connectivity, increased regional brain blood flow and volume post‐treatment, and positive responses of critical brain metabolites reflecting neuronal status and functionality in patients with AD and mild cognitive impairment. The findings have contributed to the understanding of the mechanisms underlying the medication treatments and support the crucial role of functional MRI technologies in the development and refinement of AD medication therapies.Keywords
Funding Information
- Canadian Institutes of Health Research (CSE‐125739)
- China Scholarship Council
This publication has 92 references indexed in Scilit:
- Reduction of Hippocampal Hyperactivity Improves Cognition in Amnestic Mild Cognitive ImpairmentNeuron, 2012
- Changes in regional cerebral blood flow and functional connectivity in the cholinergic pathway associated with cognitive performance in subjects with mild Alzheimer's disease after 12-week donepezil treatmentNeuroImage, 2012
- Brain Imaging in Alzheimer DiseaseCold Spring Harbor Perspectives in Medicine, 2012
- Recovery of hippocampal network connectivity correlates with cognitive improvement in mild alzheimer's disease patients treated with donepezil assessed by resting‐state fMRIJournal of Magnetic Resonance Imaging, 2011
- MR Spectroscopy and Spectroscopic Imaging of the Brain2010
- Neuropathology of Alzheimer's DiseaseMount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2010
- Memantine decreases hippocampal glutamate levels: A magnetic resonance spectroscopy studyProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2008
- Cholinesterase inhibition modulates visual and attentional brain responses in Alzheimer's disease and healthBrain, 2007
- Use of Functional Magnetic Resonance Imaging in the Early Identification of Alzheimer's DiseaseNeuropsychology Review, 2007
- Global prevalence of dementia: a Delphi consensus studyThe Lancet, 2005